Comparison of nonhematologic adverse events observed in imatinib-intolerant patients treated with nilotinib
| Grade 3/4 adverse events . | Patients with toxicity on imatinib, no. . | Patients with toxicity on nilotinib, no. . |
|---|---|---|
| Rash/skin | 25 | 0 |
| Liver toxicity | 10 | 1 |
| Fluid retention | 17 | 0 |
| Gastrointestinal intolerance | 15 | 1 |
| Musculoskeletal | 9 | 0 |
| Other | 10 | 0 |
| Total | 86 | 2 |
| Grade 3/4 adverse events . | Patients with toxicity on imatinib, no. . | Patients with toxicity on nilotinib, no. . |
|---|---|---|
| Rash/skin | 25 | 0 |
| Liver toxicity | 10 | 1 |
| Fluid retention | 17 | 0 |
| Gastrointestinal intolerance | 15 | 1 |
| Musculoskeletal | 9 | 0 |
| Other | 10 | 0 |
| Total | 86 | 2 |